SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-23-010732
Filing Date
2023-06-01
Accepted
2023-06-01 17:22:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20230601xdefa14a.htm DEFA14A 14381
2 GRAPHIC tmb-20230601xdefa14a001.jpg GRAPHIC 5566
  Complete submission text file 0001558370-23-010732.txt   23172
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38150 | Film No.: 23985723
SIC: 2834 Pharmaceutical Preparations